Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.

Abstract

Antipsychotic drugs provide limited efficacy for cognitive impairment in schizophrenia. Recent studies have found that the neurotensin NTS1 receptor agonist and putative atypical antipsychotic drug PD149163 reverses deficits in sensory-gating and novel object recognition, suggesting that this compound may have the potential to improve cognitive functioning in schizophrenia. The present study sought to extend these investigations by evaluating the effects of PD149163 on sustained attention using a visual signal detection operant task in rats. PD149163, the atypical antipsychotic drug clozapine, and the dopamine D2/3 receptor antagonist raclopride all significantly decreased percent "hit" accuracy, while none of these compounds altered "correct rejections" (compared to vehicle control). Clozapine and raclopride significantly increased response latency, while high doses of PD149163 and raclopride significantly increased trial omissions. Nicotine, which was tested as a positive control, significantly improved overall performance in this task and did not affect response latency or trial omissions. The present findings suggest that neurotensin NTS1 receptor agonists, like antipsychotic drugs, may inhibit sustained attention in this task despite having different pharmacological mechanisms of action.

• Authors: Todd M Hillhouse, Adam J Prus
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 721 Issue 1-3 Pg. 201-7 (Dec 05 2013) ISSN: 1879-0712 [Electronic] Netherlands
• PMID: 24076181 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: © 2013 Elsevier B.V. All rights reserved.

Chemical References

• PD 149163
• Receptors, Neurotensin
• neurotensin type 1 receptor
• Neurotensin

Topics

• Animals
• Attention (drug effects)
• Male
• Neurotensin (analogs & derivatives, pharmacology)
• Rats
• Rats, Sprague-Dawley
• Reaction Time (drug effects)
• Receptors, Neurotensin (agonists)
• Visual Perception (drug effects, physiology)